Página 13 de resultados Sector: Atención sanitaria Área de negocio: Biotecnología Mercado de valores: precios y cotizaciones
Lista de todas las acciones y valores con precios, capitalizaciones de mercado, P/G y EPS
Todos los países
- {{country.name}}
- Todos los países
- Estados Unidos (1011)
- Australia (58)
- Austria (16)
- Bélgica (7)
- Brasil (16)
- Canadá (83)
- China (94)
- Dinamarca (6)
- Finlandia (4)
- Francia (41)
- Alemania (737)
- Hong Kong (46)
- India (19)
- Irlanda (1)
- Israel (19)
- Italia (4)
- Japón (37)
- México (28)
- Países Bajos (3)
- Nueva Zelanda (1)
- Noruega (14)
- Polonia (9)
- Rusia (2)
- Corea del Sur (10)
- España (4)
- Suecia (70)
- Suiza (11)
- Taiwán (67)
- Tailandia (2)
- Turquía (1)
- Reino Unido (69)
Todos los intercambios
- {{item.name}}
- Todos los intercambios
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (278)
- NasdaqGM (142)
- NasdaqGS (239)
- NSE (10)
- NYSE (10)
- NYSE American (20)
- NZSE (1)
- Oslo (14)
- Other OTC (322)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (38)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Atención sanitaria (2608)
- {{item.name}}
- Todos los sectores
- Atención sanitaria (2608)
Biotecnología (2608)
- {{item.name}}
- Todas las industrias
- Biotecnología (2608)
- Fabricante de Medicamentos-General (279)
- Fabricante de Medicamentos-Especializado y Genérico (1702)
- Planes de Salud (57)
- Centros de Atención Médica (554)
- Pharmaceutical Retailers (155)
- Servicios de Información Sanitaria (420)
- Dispositivos Médicos (913)
- Instrumentos y Suministros Médicos (502)
- Diagnósticos y Análisis (427)
- Distribución Médica (138)
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA |
|---|
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Financière de Tubize SA FTD.SG | $104 113.69 USD |
+0.78
|
$4.64B 5.07B USD | $0 0 USD | $103 112.59 USD | $104 113.69 USD | $4.64B 5.07B USD | 52.00 | $2 2.19 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $38.17 41.72 USD |
+3.07
|
$4.63B 5.06B USD | $85 92.92 USD | $38.14 41.69 USD | $38.17 41.72 USD | $4.63B 5.06B USD | 0 | -$3.2 -3.4 USD | |
| ALK-Abelló A/S 4AJ0.F | $20.16 22.04 USD |
+0.7
|
$4.57B 5B USD | $15 16.4 USD | $20.16 22.04 USD | $20.16 22.04 USD | $4.57B 5B USD | 57.60 | $0.35 0.38 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $88.5 96.74 USD |
+3.57
|
$4.53B 4.95B USD | $1 1.09 USD | $87.05 95.16 USD | $88.5 96.74 USD | $4.53B 4.95B USD | 34.30 | $2.58 2.82 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $23.4 25.58 USD |
+7.44
|
$4.44B 4.85B USD | $200 218.63 USD | $23.4 25.58 USD | $23.41 25.59 USD | $4.44B 4.85B USD | 0 | -$3.02 -3.3 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $77,500 58.5 USD |
+2.38
|
$6.07T 4.58B USD | $89.05K 67.22 USD | $74,900 56.54 USD | $77,500 58.5 USD | $6.07T 4.58B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| ImmunityBio, Inc. 26CA.F | $5.82 6.36 USD |
-3.03
|
$4.07B 4.45B USD | $300 327.94 USD | $5.82 6.36 USD | $6.03 6.59 USD | $4.07B 4.45B USD | 0 | -$1.01 -1.1 USD | |
| ALK-Abelló A/S 0OIR.IL | $149.45 21.91 USD |
0
|
$30B 4.4B USD | $10.6K 1.55K USD | $151.9 22.27 USD | $153.2 22.46 USD | $30B 4.4B USD | 92.82 | $1.61 0.24 USD | |
| Akeso, Inc. 4RY.F | $4.48 4.9 USD |
-2.18
|
$3.88B 4.24B USD | $360 393.53 USD | $4.42 4.83 USD | $4.48 4.9 USD | $3.88B 4.24B USD | 14.45 | $0.31 0.34 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Merus N.V. 2GH.F | $55.5 60.67 USD |
+5.71
|
$3.74B 4.09B USD | $30 32.79 USD | $55.5 60.67 USD | $55.5 60.67 USD | $3.74B 4.09B USD | 0 | -$2.55 -2.7 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| Axsome Therapeutics, Inc. 19X.F | $74.02 80.91 USD |
+0.33
|
$3.57B 3.9B USD | $100 109.31 USD | $74.02 80.91 USD | $74.06 80.96 USD | $3.57B 3.9B USD | 0 | -$6.03 -6.5 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $38.6 42.2 USD |
+2.12
|
$3.5B 3.82B USD | $21 22.96 USD | $38.6 42.2 USD | $38.6 42.2 USD | $3.5B 3.82B USD | 0 | -$7.42 -8.1 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $40.6 44.38 USD |
+3.57
|
$3.3B 3.61B USD | $40 43.73 USD | $40.6 44.38 USD | $40.6 44.38 USD | $3.3B 3.61B USD | 0 | -$3.52 -3.8 USD | |
| Denali Therapeutics Inc. 4DN.F | $21.38 23.37 USD |
+4.75
|
$3.21B 3.51B USD | $22 24.05 USD | $21.38 23.37 USD | $21.38 23.37 USD | $3.21B 3.51B USD | 0 | -$0.88 -0.9 USD | |
| Denali Therapeutics Inc. 4DN.MU | $21.34 23.33 USD |
+3.19
|
$3.17B 3.46B USD | $74 80.89 USD | $21.34 23.33 USD | $21.34 23.33 USD | $3.17B 3.46B USD | 0 | -$0.88 -0.9 USD | |
| Corcept Therapeutics Incorporated HTD.F | $29.89 32.67 USD |
+1.12
|
$3.16B 3.45B USD | $50 54.66 USD | $29.63 32.39 USD | $29.89 32.67 USD | $3.16B 3.45B USD | 30.49 | $0.98 1.07 USD | |
| Syngene International Limited SYNGENE.BO | $709.8 8.59 USD |
-0.29
|
$284.84B 3.45B USD | $17.61K 213.05 USD | $708.55 8.57 USD | $719 8.7 USD | $284.84B 3.45B USD | 55.84 | $12.71 0.15 USD | |
| Camurus AB (publ) 7CA.F | $52.05 56.9 USD |
+0.97
|
$3.07B 3.35B USD | $58 63.4 USD | $52.05 56.9 USD | $52.05 56.9 USD | $3.07B 3.35B USD | 75.43 | $0.69 0.75 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $5.55 6.07 USD |
0
|
$3.05B 3.33B USD | $38 41.54 USD | $5.55 6.07 USD | $5.55 6.07 USD | $3.05B 3.33B USD | 8.16 | $0.68 0.74 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $23.85 26.07 USD |
-2.09
|
$3.01B 3.29B USD | $20 21.86 USD | $23.85 26.07 USD | $23.85 26.07 USD | $3.01B 3.29B USD | 0 | -$3.95 -4.3 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $1 1.09 USD | $44.18 48.29 USD | $44.47 48.61 USD | $2.93B 3.2B USD | 0 | -$1.92 -2.09 USD | |
| VitaSpring Biomedical VSBC | $15 — |
0
|
$3.1B — | $242 — | $15 — | $15 — | $3.1B — | 0 | $0 — | |
| SK bioscience Co.,Ltd. 302440.KS | $52,600 39.7 USD |
-1.31
|
$4.04T 3.05B USD | $273.51K 206.46 USD | $51,700 39.03 USD | $54,100 40.84 USD | $4.04T 3.05B USD | 0 | $0 0 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $35 38.26 USD |
+2.94
|
$2.75B 3.01B USD | $20 21.86 USD | $35 38.26 USD | $35 38.26 USD | $2.75B 3.01B USD | 0 | -$2.54 -2.7 USD | |
| Amicus Therapeutics, Inc. AM6.F | $9.15 10 USD |
+2.23
|
$2.74B 3B USD | $850 929.16 USD | $9.15 10 USD | $9.15 10 USD | $2.74B 3B USD | 0 | -$0.46 -0.5 USD | |
| TG Therapeutics, Inc. NKB2.F | $16.64 18.19 USD |
+1.34
|
$2.57B 2.81B USD | $250 273.28 USD | $16.64 18.19 USD | $16.64 18.19 USD | $2.57B 2.81B USD | 59.42 | $0.28 0.31 USD | |
| MorphoSys AG MOR.VI | $67.8 74.11 USD |
+0.22
|
$2.55B 2.79B USD | $0 0 USD | $67.7 74.01 USD | $67.8 74.11 USD | $2.55B 2.79B USD | 0 | -$5.53 -6.04 USD | |
| MorphoSys AG MOR2.F | $16.5 18.04 USD |
+1.23
|
$2.55B 2.78B USD | $40 43.73 USD | $16.5 18.04 USD | $16.5 18.04 USD | $2.55B 2.78B USD | 0 | -$1.38 -1.5 USD | |
| MorphoSys AG MOR.F | $67.6 73.9 USD |
+0.6
|
$2.55B 2.78B USD | $30 32.79 USD | $67.15 73.4 USD | $67.6 73.9 USD | $2.55B 2.78B USD | 0 | -$5.53 -6.04 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $15.22 16.63 USD |
+5.95
|
$2.51B 2.75B USD | $180 196.76 USD | $15.22 16.63 USD | $15.22 16.63 USD | $2.51B 2.75B USD | 0 | $0 0 USD | |
| MorphoSys AG MPSYF | $71.76 — |
+0.53
|
$2.73B — | $100 — | $71.76 — | $71.76 — | $2.73B — | 0 | -$5.91 — | |
| Geron Corporation GON.F | $4.18 4.57 USD |
+2.2
|
$2.48B 2.71B USD | $30 32.79 USD | $4.09 4.47 USD | $4.18 4.57 USD | $2.48B 2.71B USD | 0 | -$0.32 -0.3 USD | |
| Celldex Therapeutics, Inc. TCE2.F | $35.2 38.48 USD |
+4.14
|
$2.42B 2.65B USD | $19 20.77 USD | $35.2 38.48 USD | $35.2 38.48 USD | $2.42B 2.65B USD | 0 | -$2.68 -2.9 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $32 34.98 USD |
-1.23
|
$2.42B 2.65B USD | $420 459.12 USD | $32 34.98 USD | $32 34.98 USD | $2.42B 2.65B USD | 0 | -$1.87 -2.04 USD | |
| IDEAYA Biosciences, Inc. 30J.SG | $31.2 34.11 USD |
-1.27
|
$2.4B 2.63B USD | $0 0 USD | $31.2 34.11 USD | $31.2 34.11 USD | $2.4B 2.63B USD | 0 | -$1.87 -2.04 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $37.4 40.88 USD |
+1.63
|
$2.34B 2.56B USD | $50 54.66 USD | $37.4 40.88 USD | $37.4 40.88 USD | $2.34B 2.56B USD | 0 | -$4.32 -4.7 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $40.4 44.16 USD |
+1
|
$2.29B 2.51B USD | $40 43.73 USD | $40.4 44.16 USD | $40.4 44.16 USD | $2.29B 2.51B USD | 0 | -$5.89 -6.4 USD | |
| BB Biotech AG BBZA.F | $41.55 45.42 USD |
-0.6
|
$2.29B 2.5B USD | $1.12K 1.23K USD | $41.2 45.04 USD | $42.05 45.97 USD | $2.29B 2.5B USD | 7.12 | $5.83 6.37 USD | |
| Vericel Corporation ATQP.F | $43.6 47.66 USD |
+3.32
|
$2.21B 2.41B USD | $5 5.47 USD | $43.6 47.66 USD | $43.6 47.66 USD | $2.21B 2.41B USD | 4360.00 | $0.01 0.01 USD | |
| Bavarian Nordic A/S 0DPB.IL | $173.58 25.45 USD |
-6.47
|
$16.29B 2.39B USD | $17.6K 2.58K USD | $173.45 25.43 USD | $188 27.56 USD | $16.29B 2.39B USD | 12.31 | $14.09 2.07 USD | |
| Iovance Biotherapeutics, Inc. 2LB.F | $7.44 8.13 USD |
-0.67
|
$2.09B 2.29B USD | $200 218.63 USD | $7.44 8.13 USD | $7.44 8.13 USD | $2.09B 2.29B USD | 0 | -$1.69 -1.8 USD | |
| Genscript Biotech Corporation G51.F | $0.9799 1.07 USD |
-2
|
$2.08B 2.28B USD | $1K 1.09K USD | $0.9799 1.07 USD | $0.9799 1.07 USD | $2.08B 2.28B USD | 0 | -$0.04 -0.04 USD | |
| BioArctic AB (publ) 0RV2.IL | $227.1 22.17 USD |
+2.16
|
$22.72B 2.22B USD | $4.59K 448.14 USD | $224.6 21.92 USD | $230.8 22.53 USD | $22.72B 2.22B USD | 73.97 | $3.07 0.3 USD | |
| Intellia Therapeutics, Inc. 38I.F | $20.91 22.86 USD |
-4.78
|
$2.02B 2.21B USD | $68 74.33 USD | $20.91 22.86 USD | $21.86 23.9 USD | $2.02B 2.21B USD | 0 | -$5.01 -5.4 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $661 722.56 USD | $25 27.33 USD | $25.73 28.13 USD | $1.99B 2.18B USD | 45.17 | $0.56 0.61 USD | |
| Novavax, Inc. NVAX.MX | $229 13.56 USD |
-2.84
|
$34.39B 2.04B USD | $1.3K 76.98 USD | $228 13.5 USD | $238.7 14.13 USD | $34.39B 2.04B USD | 0 | -$56.24 -3.3 USD | |
| 3SBio Inc. 83B.F | $0.6899 0.75 USD |
+0.73
|
$1.86B 2.03B USD | $1K 1.09K USD | $0.6899 0.75 USD | $0.6899 0.75 USD | $1.86B 2.03B USD | 8.62 | $0.08 0.09 USD | |
| PeptiDream PPTDF | $14.3 — |
0
|
$2.01B — | $200 — | $14.3 — | $14.3 — | $2.01B — | 119.16 | $0.12 — | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | $17.08 18.67 USD |
-12.72
|
$1.83B 2B USD | $100 109.31 USD | $17.08 18.67 USD | $19.65 21.47 USD | $1.83B 2B USD | 0 | -$2.66 -2.9 USD | |
| Bavarian Nordic A/S BV3.F | $23.09 25.24 USD |
-8.37
|
$1.8B 1.97B USD | $2.27K 2.48K USD | $22.97 25.11 USD | $25.19 27.54 USD | $1.8B 1.97B USD | 13.66 | $1.69 1.85 USD | |
| BioArctic AB (publ) B9A.F | $19.89 21.74 USD |
+1.43
|
$1.8B 1.97B USD | $95 103.85 USD | $19.3 21.1 USD | $19.89 21.74 USD | $1.8B 1.97B USD | 0 | -$0.12 -0.1 USD | |
| Bavarian Nordic A/S BVNRY | $8.26 — |
-7.81
|
$1.93B — | $1.3K — | $8.26 — | $8.33 — | $1.93B — | 13.76 | $0.6 — | |
| Galapagos GLPGF | $26.2 — |
-27.62
|
$1.9B — | $190 — | $26.2 — | $26.2 — | $1.9B — | 52.39 | $0.5 — | |
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | $3.74 4.09 USD |
+2.19
|
$1.72B 1.88B USD | $290 317.01 USD | $3.74 4.09 USD | $3.74 4.09 USD | $1.72B 1.88B USD | 16.26 | $0.23 0.25 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $13.85 15.14 USD |
-0.18
|
$1.71B 1.87B USD | $2K 2.19K USD | $13.85 15.14 USD | $13.85 15.14 USD | $1.71B 1.87B USD | 26.63 | $0.52 0.57 USD | |
| Maravai LifeSciences Holdings, Inc. MAR.F | $6.6 7.21 USD |
+0.76
|
$1.69B 1.85B USD | $500 546.57 USD | $6.55 7.16 USD | $6.75 7.38 USD | $1.69B 1.85B USD | 0 | -$0.92 -1.005 USD | |
| Morphic Holding, Inc. 31Y.F | $31.4 34.32 USD |
+5.37
|
$1.68B 1.84B USD | $750 819.85 USD | $30.8 33.67 USD | $31.4 34.32 USD | $1.68B 1.84B USD | 0 | -$3.37 -3.6 USD | |
| Galapagos NV G1LP34.SA | $6.99 1.42 USD |
+1.6
|
$9.06B 1.84B USD | $29 5.88 USD | $6.93 1.4 USD | $6.99 1.42 USD | $9.06B 1.84B USD | 2.52 | $2.77 0.56 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| Syndax Pharmaceuticals, Inc. 1T3.F | $18.6 20.33 USD |
+2.2
|
$1.65B 1.81B USD | $100 109.31 USD | $18.6 20.33 USD | $18.6 20.33 USD | $1.65B 1.81B USD | 0 | -$3.03 -3.3 USD | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Bavarian Nordic A/S BVNKF | $21.2 — |
0
|
$1.77B — | $1 — | $21.2 — | $21.2 — | $1.77B — | 11.77 | $1.8 — | |
| Zai Lab Limited 1ZL.F | $16.1 17.6 USD |
+1.26
|
$1.6B 1.74B USD | $25 27.33 USD | $16.1 17.6 USD | $16.1 17.6 USD | $1.6B 1.74B USD | 0 | -$3.27 -3.5 USD | |
| Veracyte, Inc. 12V.F | $20.8 22.74 USD |
-0.95
|
$1.59B 1.74B USD | $7 7.65 USD | $20.8 22.74 USD | $20.8 22.74 USD | $1.59B 1.74B USD | 0 | -$0.87 -0.9 USD | |
| Immunocore Holdings plc 6YG.F | $31.2 34.11 USD |
0
|
$1.58B 1.73B USD | $100 109.31 USD | $30.8 33.67 USD | $31.4 34.32 USD | $1.58B 1.73B USD | 0 | -$1.44 -1.5 USD | |
| Neuren Pharmaceuticals NURPF | $13.15 — |
0
|
$1.71B — | $100 — | $13.15 — | $13.15 — | $1.71B — | 16.43 | $0.8 — | |
| Immunocore Holdings plc 6YG.MU | $31 33.89 USD |
-0.64
|
$1.55B 1.69B USD | $13 14.21 USD | $31 33.89 USD | $31 33.89 USD | $1.55B 1.69B USD | 0 | -$1.32 -1.4 USD | |
| Galapagos NV GLPG.VI | $23.46 25.64 USD |
+0.17
|
$1.55B 1.69B USD | $0 0 USD | $23.46 25.64 USD | $23.46 25.64 USD | $1.55B 1.69B USD | 49.91 | $0.47 0.51 USD | |
| Galapagos NV GXE.F | $23.02 25.16 USD |
-0.86
|
$1.54B 1.68B USD | $120 131.18 USD | $23.02 25.16 USD | $23.28 25.45 USD | $1.54B 1.68B USD | 48.97 | $0.47 0.51 USD | |
| Galapagos NV GXEA.F | $23.2 25.36 USD |
-0.85
|
$1.54B 1.68B USD | $386 421.95 USD | $23.2 25.36 USD | $23.4 25.58 USD | $1.54B 1.68B USD | 49.36 | $0.47 0.51 USD | |
| Ardelyx, Inc. 41X.F | $6 6.56 USD |
+7.14
|
$1.53B 1.67B USD | $120 131.18 USD | $6 6.56 USD | $6 6.56 USD | $1.53B 1.67B USD | 0 | -$0.26 -0.2 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $397.93 23.56 USD |
0
|
$28.11B 1.66B USD | $0 0 USD | $397.93 23.56 USD | $397.93 23.56 USD | $28.11B 1.66B USD | 0 | -$105.76 -6.2 USD | |
| Akero Therapeutics, Inc. 0K4.F | $21.3 23.28 USD |
+0.14
|
$1.52B 1.66B USD | $1.68K 1.83K USD | $21.3 23.28 USD | $21.73 23.75 USD | $1.52B 1.66B USD | 0 | -$3.03 -3.3 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $30.2 33.01 USD |
0
|
$1.5B 1.65B USD | $6 6.56 USD | $30.2 33.01 USD | $30.4 33.23 USD | $1.5B 1.65B USD | 0 | -$3.49 -3.8 USD | |
| Kura Oncology, Inc. KUR.F | $18.98 20.74 USD |
-0.52
|
$1.47B 1.6B USD | $50 54.66 USD | $18.98 20.74 USD | $18.98 20.74 USD | $1.47B 1.6B USD | 0 | -$2.03 -2.2 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $77 84.17 USD |
+6.21
|
$1.41B 1.54B USD | $1 1.09 USD | $77 84.17 USD | $77 84.17 USD | $1.41B 1.54B USD | 15.40 | $5 5.47 USD | |
| Biotest Aktiengesellschaft BIO.DE | $42.2 46.13 USD |
+2.93
|
$1.4B 1.53B USD | $222 242.68 USD | $41.6 45.47 USD | $42.2 46.13 USD | $1.4B 1.53B USD | 9.44 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO3.DE | $26.7 29.19 USD |
+1.14
|
$1.38B 1.51B USD | $356 389.16 USD | $26.1 28.53 USD | $26.8 29.3 USD | $1.38B 1.51B USD | 5.97 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO.F | $40.8 44.6 USD |
+0.49
|
$1.37B 1.5B USD | $100 109.31 USD | $40.8 44.6 USD | $40.8 44.6 USD | $1.37B 1.5B USD | 9.12 | $4.47 4.89 USD | |
| Biotest Aktiengesellschaft BIO3.VI | $26.5 28.97 USD |
-0.75
|
$1.36B 1.49B USD | $0 0 USD | $26.5 28.97 USD | $26.8 29.3 USD | $1.36B 1.49B USD | 5.92 | $4.47 4.89 USD | |
| Genus GENSF | $22 — |
0
|
$1.46B — | $1K — | $22 — | $22 — | $1.46B — | 34.37 | $0.64 — | |
| MannKind Corporation NNFN.F | $4.89 5.34 USD |
+2.43
|
$1.33B 1.46B USD | $1.5K 1.64K USD | $4.89 5.34 USD | $4.89 5.34 USD | $1.33B 1.46B USD | 122.20 | $0.04 0.04 USD | |
| Biotest Aktiengesellschaft BIO3.F | $26.2 28.64 USD |
-2.96
|
$1.32B 1.45B USD | $120 131.18 USD | $25.8 28.2 USD | $26.2 28.64 USD | $1.32B 1.45B USD | 5.86 | $4.47 4.89 USD | |
| Bicycle Therapeutics plc 50BA.F | $18.9 20.66 USD |
+0.53
|
$1.31B 1.44B USD | $230 251.42 USD | $18.1 19.79 USD | $18.9 20.66 USD | $1.31B 1.44B USD | 0 | -$4.12 -4.5 USD | |
| Genus plc GBE.F | $19.3 21.1 USD |
0
|
$1.29B 1.41B USD | $100 109.31 USD | $19.3 21.1 USD | $19.3 21.1 USD | $1.29B 1.41B USD | 32.16 | $0.6 0.66 USD | |
| Lexicon Pharmaceuticals, Inc. LX31.MU | $3.53 3.86 USD |
0
|
$1.28B 1.39B USD | $250 273.28 USD | $3.53 3.86 USD | $3.53 3.86 USD | $1.28B 1.39B USD | 0 | -$0.55 -0.6 USD | |
| Vir Biotechnology, Inc. VIR.MX | $172 10.18 USD |
0
|
$23.4B 1.39B USD | $0 0 USD | $172 10.18 USD | $172 10.18 USD | $23.4B 1.39B USD | 0 | -$78.1 -4.6 USD | |
| POINT Biopharma Global PNT | $12.5 — |
0
|
$1.33B — | $0 — | $0 — | $0 — | $1.33B — | 0 | $0 — | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $5.66 6.19 USD |
-0.84
|
$1.19B 1.3B USD | $500 546.57 USD | $5.66 6.19 USD | $5.66 6.19 USD | $1.19B 1.3B USD | 0 | -$1 -1.09 USD | |
| Verona Pharma plc I9SA.F | $14 15.3 USD |
+0.72
|
$1.14B 1.24B USD | $75 81.99 USD | $13.7 14.98 USD | $14 15.3 USD | $1.14B 1.24B USD | 0 | -$0.75 -0.8 USD | |
| Immatics N.V. 4A3.F | $10.81 11.82 USD |
-0.92
|
$1.13B 1.23B USD | $1.25K 1.37K USD | $10.81 11.82 USD | $11.16 12.2 USD | $1.13B 1.23B USD | 0 | -$0.98 -1.07 USD | |
| CTI BioPharma CTIC | $9.07 — |
0
|
$1.2B — | $0 — | $0 — | $0 — | $1.2B — | 0 | $0 — | |
| Xencor, Inc. XE9.F | $17.7 19.35 USD |
0
|
$1.09B 1.19B USD | $300 327.94 USD | $17.7 19.35 USD | $17.7 19.35 USD | $1.09B 1.19B USD | 0 | -$2.03 -2.2 USD | |
|
Sin acciones favoritas
Aún no tiene una acción favorita, agréguela a favoritos para verla aquí |
||||||||||